PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1379266
PUBLISHER: Visiongain Reports Ltd. | PRODUCT CODE: 1379266
The global mRNA Vaccines market is projected to grow at a CAGR of 10.5% by 2033.
“The mRNA Vaccines Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Extensive research has been conducted on mRNA vaccines as potential cancer therapeutics for a period exceeding two decades, yielding limited success. In recent times, there has been a notable surge in research attention towards cancer vaccines. This surge has been prompted by the remarkable and enduring responses witnessed in certain malignancies through the use of immune checkpoint inhibitors, as well as advancements in technology. The initiation of a phase 3 clinical trial for the personalised vaccine mRNA-4157 (also referred to as V940) in conjunction with pembrolizumab (commonly known as Keytruda) was announced by Moderna and Merck on 26 July 2023. This trial aims to evaluate the efficacy of the combination therapy in high-risk patients who have previously undergone surgical intervention for melanoma. The objective of the trial is to recruit a total of 1,089 patients who are at stages IIb to IV. The primary endpoint of the trial is to assess the post-surgical recurrence-free survival of these patients. The conclusive outcomes are anticipated to be available by the year 2029.
mRNA vaccines projects taking place now and over the next 10 years?
You need to discover how this will impact the mRNA vaccines market today, and over the next 10 years:
This report tells you TODAY how the mRNA vaccines market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:
The report also includes profiles and for some of the leading companies in the mRNA Vaccines Market, 2023 to 2033, with a focus on this segment of these companies' operations.
|
|
Overall world revenue for mRNA Vaccines Market, 2023 to 2033 in terms of value the market will surpass US$11,700.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
In summary, our 210+ page report provides you with the following knowledge:
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the mRNA Vaccines Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.